TAG:
informatics
Prognostic versus Diagnostic Lab Medicine
By R. Lewis Dark | From the Volume VII No. 16 – November 13, 2000 Issue
MOST OF YOU ARE FAMILIAR WITH THE RACE TO DEVELOP effective laboratory tests and pharmaceuticals based on rapidly-developing genetic and molecular knowledge. We all ask the same question: when will my laboratory have to buy this technology and offer these new tests? For most of us, the answer is “…
AmeriPath Will Acquire Inform DX for $44.6 Mil
By Robert Michel | From the Volume VII No. 16 – November 13, 2000 Issue
CEO SUMMARY: It’s another example of consolidation in the anatomic pathology marketplace. AmeriPath, Inc.’s acquisition of Inform DX, Inc. positions the company to do as much as $350 million in revenues next year. By acquiring Inform DX, AmeriPath also gains entry into six more states…
AmeriPath & InformDX Merging To Form Largest Anatomic Pathology Firm in U.S.
By Robert Michel | From the Volume VII No. 16 – November 13, 2000 Issue
CEO SUMMARY: AmeriPath and InformDX shared several common elements in their respective business strategies. Both companies believe that pathology services are best delivered at the local level and benefit from the support of a national organization. Both companies believe that physicians …
“August 21, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 12 – August 21, 2000 Issue
Bio-Reference Laboratories, Inc. (BRLI) announced that its physician Web portal service, CareEvolve.com, gained 200 enrolled physicians in the first eight days following its August 1, 2000 release. As a laboratory company, BRLI recognizes that its physician network is the real asset …
Dr. Bruce Friedman Identifies Market Dynamics Driving Evolution of Lab Information Services
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Probably no one is better positioned to identify the evolution of laboratory information services than Bruce Friedman, M.D., Professor of Pathology at the University of Michigan Medical School in Ann Arbor. For almost 20 years, he has hosted the pre-eminent meeting in laborat…
2000’s Movers & Shakers Represent Strong Leaders
By Robert Michel | From the Volume VII No. 5 – March 27, 2000 Issue
CEO SUMMARY: Its time again for THE DARK REPORT to make its yearly selection of the lab industry’s Movers & Shakers. Individuals chosen for 2000 represent a cross section of laboratory companies. Their successes demonstrate that leadership and vision continue to make a difference, d…
Honolulu Lab Pursuing Pacific Rim Business
By Robert Michel | From the Volume VII No. 5 – March 27, 2000 Issue
CEO SUMMARY: With one laboratory already operating in Guam, Diagnostic Laboratory Services, Inc. (DLS) is poised to expand its services in the Pacific Rim area. Now a major competitor within Hawaii, DLS sees the island archipelagos of the Pacific Ocean as a natural extension of its existi…
Park City Solutions, DIANON, IMPATH American Med Labs, Cytyc, TriPath Imaging
By Robert Michel | From the Volume VII No. 4 – March 6, 2000 Issue
PARK CITY SOLUTIONS AND AMERICAN MEDICAL LABS CREATE STRATEGIC PACT TWO COMPANIES FINANCED by GTCR Golder Rauner, LLC, the private equity firm based in Chicago, announced a strategic relationship. Park City Solutions, Inc. of Park City, Utah and Ame…
Pathology Profession Facing New Directions
By Robert Michel | From the Volume VII No. 2 – January 24, 2000 Issue
CEO SUMMARY: Big changes ahead during the next decade. Among the predictions: the number of two and three-pathologist group practices will radically diminish; pathology centers of excellence will achieve new market dominance; and…ever more intense competition for anatomic pathology spec…
Epitope, LabOne, CARESIDE, Quest, Structural Bioinformatics, UroCor
By Robert Michel | From the Volume VII No. 2 – January 24, 2000 Issue
EPITOPE RAIDS LABONE FOR NEW PRESIDENT/CEO; READIES DRUGS OF ABUSE MARKET LAUNCH DURING THE YEAR 2000, Epitope, Inc., based in Portland, Oregon, plans to introduce a drugs of abuse test based on its patented OraSure® oral collection technology. To aid in this new product l…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized